Josephson B, Fehl C, Isenegger P, Nadal S, Wright T, Poh A
Nature. 2020; 585(7826):530-537.
PMID: 32968259
DOI: 10.1038/s41586-020-2733-7.
Bolt A, Klimecki W
J Appl Toxicol. 2012; 32(7):465-79.
PMID: 22334383
PMC: 3572937.
DOI: 10.1002/jat.1787.
Khandros E, Weiss M
Hematol Oncol Clin North Am. 2010; 24(6):1071-88.
PMID: 21075281
PMC: 4136498.
DOI: 10.1016/j.hoc.2010.08.013.
Meriin A, Mabuchi K, Gabai V, Yaglom J, Kazantsev A, Sherman M
J Cell Biol. 2001; 153(4):851-64.
PMID: 11352944
PMC: 2192371.
DOI: 10.1083/jcb.153.4.851.
Callis J, Bedinger P
Proc Natl Acad Sci U S A. 1994; 91(13):6074-7.
PMID: 7517039
PMC: 44140.
DOI: 10.1073/pnas.91.13.6074.
Degradation of acetylcholine receptors in muscle cells: effect of leupeptin on turnover rate, intracellular pool sizes, and receptor properties.
Hyman C, Froehner S
J Cell Biol. 1983; 96(5):1316-24.
PMID: 6841450
PMC: 2112642.
DOI: 10.1083/jcb.96.5.1316.
Denatured proteins are degraded more rapidly than abnormal proteins in cell-free extracts of Saccharomyces cerevisiae.
Chopra A, Chaloupka J
Folia Microbiol (Praha). 1984; 29(4):343-5.
PMID: 6383975
DOI: 10.1007/BF02875968.
Proinsulin modified by analogues of arginine and lysine is degraded rapidly in pancreatic B-cells.
Halban P, Amherdt M, Orci L, Renold A
Biochem J. 1984; 219(1):91-7.
PMID: 6372788
PMC: 1153452.
DOI: 10.1042/bj2190091.
Energy requirement for degradation of tumor-associated protein p53.
Gronostajski R, GOLDBERG A, Pardee A
Mol Cell Biol. 1984; 4(3):442-8.
PMID: 6325878
PMC: 368721.
DOI: 10.1128/mcb.4.3.442-448.1984.
Disulfide bonds and thermal stability in T4 lysozyme.
Wetzel R, Perry L, Baase W, Becktel W
Proc Natl Acad Sci U S A. 1988; 85(2):401-5.
PMID: 3277175
PMC: 279556.
DOI: 10.1073/pnas.85.2.401.
Turnover of abnormal proteins in Bacillus megaterium and Saccharomyces cerevisiae: differences between in vivo and in vitro degradation.
Chopra A, Strnadova M, Chaloupka J
Arch Microbiol. 1986; 145(1):97-103.
PMID: 3092778
DOI: 10.1007/BF00413034.
Hemoglobin Mississippi (beta 44ser----cys). Studies of the thalassemic phenotype in a mixed heterozygote with beta +-thalassemia.
Steinberg M, Adams 3rd J, Morrison W, Pullen D, Abney R, Ibrahim A
J Clin Invest. 1987; 79(3):826-32.
PMID: 2434529
PMC: 424211.
DOI: 10.1172/JCI112890.
